Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 mars 2012 08h34 HE | Source: Arch Biopartners Inc.

Arch Biopartners Announces Private Placement

TORONTO, ONTARIO--(Marketwire - March 20, 2012) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) announced today it intends to raise up to $250,000 via a...
15 mars 2012 11h12 HE | Source: Arch Biopartners Inc.

Arch Awarded Funding from the Government of Canada to Develop Brain Tumour Targeting Technology

TORONTO, CANADA--(Marketwire - March 15, 2012) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) today announced that the National Research Council of Canada -...
28 févr. 2012 09h21 HE | Source: Arch Biopartners Inc.

Arch Scientists to Lead Anti Corrosion Project for Auto Industry

TORONTO, ONTARIO--(Marketwire - Feb. 28, 2012) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) today announced that AUTO21 and its contributing partners have...
24 janv. 2012 13h33 HE | Source: Arch Biopartners Inc.

Arch Biopartners Appoints Claude Allary as Special Advisor

TORONTO, ONTARIO--(Marketwire - Jan. 24, 2012) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) announced today Claude Allary has been appointed Special Advisor to...
19 déc. 2011 13h43 HE | Source: Arch Biopartners Inc.

Arch Scientists Inhibit Biofilm Formation and Increase Hardness on Titantium

TORONTO, ONTARIO--(Marketwire - Dec. 19, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Biophysics Ltd today announced that Arch...
07 nov. 2011 07h31 HE | Source: Arch Biopartners Inc.

Arch Biopartners Engages Intertek Cantox to Devise Drug Development Plan for Lead Cancer Compound

TORONTO, ONTARIO--(Marketwire - Nov. 7, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) today announced it has engaged Intertek Cantox ("Cantox") to devise the...
07 sept. 2011 08h56 HE | Source: Arch Biopartners Inc.

Arch Biopartners Identify Lead Compound for Pancreatic Cancer and Non Small Cell Lung Cancer

TORONTO, ONTARIO--(Marketwire - Sept. 7, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) today announced it has identified a lead compound, named GH501a, for...
18 juil. 2011 08h55 HE | Source: Arch Biopartners Inc.

Arch Biopartners Hires Investor Relations Firm

TORONTO, ONTARIO--(Marketwire - July 18, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) announced today it has retained the services of Renmark Financial...
14 juil. 2011 08h22 HE | Source: Arch Biopartners Inc.

Arch Biopartners Announces Issuance of New U.S. Patent for Biofilm Inhibitor

TORONTO, ONTARIO--(Marketwire - July 14, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) today announced the U.S. Patent and Trademark Office has issued a method and...
06 juil. 2011 16h43 HE | Source: Arch Biopartners Inc.

Arch Biopartners, U of Calgary Extend Agreement

TORONTO, ONTARIO--(Marketwire - July 6, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) today announced that the University of Calgary has extended the...

Page précédente